Adam Hage

7PUBLICATIONS

32CO-AUTHORS

Medical infection agents (incl. prions)Nanotoxicology, health and safetyVeterinary virologyMedical molecular engineering of nucleic acids and proteinsAgricultural molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 06, 2026

Restraint of Powassan virus replication by TRIM5α facilitates viral avoidance of antiviral immunity.

|Apr 26, 2025

A No-Brainer! The Therapeutic Potential of TRIM Proteins in Viral and Central Nervous System Diseases.

Adam Hage, Mikhaila Janes, Sonja M Best

|Nov 30, 2024

TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication.

Maria Gonzalez-Orozco, Hsiang-Chi Tseng, Adam Hage

|Sep 28, 2024

AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2.

Gayatri Subramanian, Adam Hage, Friederike Feldmann

|Jul 01, 2024

TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication.

Maria Gonzalez-Orozco, Hsiang-Chi Tseng, Adam Hage

|Nov 25, 2023

<i>Pteropus vampyrus</i> TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors.

Sarah van Tol, Adam Hage, Ricardo Rajsbaum

Pageof 2

Frequent Collaborators

Ricardo Rajsbaum

Sarah van Tol

Alexander N Freiberg

Matthew Bashton

Hsiang-Chi Tseng

Hongjie Xia

Rafael J Najmanovich

Vineet Menachery

Sonja M Best

Yoatzin Peñaflor-Tellez

Frequent Collaborators

Ricardo Rajsbaum

Sarah van Tol

Alexander N Freiberg

Matthew Bashton